HCPLive® peer-to-peer panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.
In an upcoming Peer Exchange program entitled “Dual-Orexin Receptor Antagonists for Treatment of Insomnia” Dr Paul Doghramji will moderate a conversation with physicians about this class of agents for treatment of insomnia and discuss other therapeutic advancements in the field.
Expert cardiologists discuss the role of non-statin therapies in lowering LDL cholesterol, recent clinic trial data on who can benefit, as well as how to implement these agents into your clinical practice.
Expert dermatologists discuss the use of Janus kinase (JAK) inhibitors for the treatment of atopic dermatitis (AD). They review the nuances of currently approved JAK inhibitors, share treatment considerations for AD, and discuss utilizing JAK inhibitors in clinical practice.
A straight forward approach to taking care of patients with Hepatitis C. Experts in the field are offering a simplified overview for new providers on the who, what, where and when of hepatitis C care, as well as practical tips for treatment implementation
Dermatologists discuss the burdens, unmet needs, and emerging treatment options for patients with seborrheic dermatitis, offering clinical insights on therapeutic approaches and the importance of patient-centered care.
Expert cardiologists discuss strategies to improve control of LDL-cholesterol in high-risk individuals as well as real world data on reaching LDL-cholesterol thresholds. They will cover emerging therapies for lipid lowering and strategies to help implement lipid lowering therapies into your clinical practice.
Expert endocrinologists explore the pathophysiology of type 1 diabetes (T1D) and delve into screening and staging processes. They discuss strategies for delaying its onset and provide insight into the future of T1D management.
Experts present the current landscape of treatment for patients with fibromyalgia (FM), highlighting its pathophysiology and risk factors, the importance of integrative care, and three recent FDA agents approved for treatment.
An expert panel discusses new evidence to guide personalized care in heart failure. They focus on updates in the most recent heart failure guidelines, review guideline-directed medical therapy, and discuss the new clinical trial data in specific patient populations.
Experts in hepatology discuss recent updates in primary biliary cholangitis (PBC) treatment and monitoring. They review recently published real-world data and share their approach to personalizing treatment and what is on the horizon for PBC care.
A panel of experts discuss the role of type 2 inflammation in asthma, challenges with long-term use of corticosteroids, and the emerging role of biologics and various mechanisms of actions in the management of asthma.
Experts discuss therapies and sequencing strategies for treating inflammatory bowel disease, highlight the efficacy and safety of these treatments, and explore prospective advances in the care of patience with inflammatory bowel disease.
Experts in dermatology focus on how new and advanced treatments are impacting the quality of life for individuals with atopic dermatitis (AD). They explore how to optimize the patient experience by utilizing these therapies in a strategic matter.
Experts in dermatology discuss the pathophysiology of vitiligo, current standards of care, and new and emerging therapies. They also explore evidence-based approaches and patient-centered care to manage vitiligo and improve patient outcomes.
Expert dermatologists discuss 3 patient case scenarios and their approach to finding the best treatment for each patient type. They discuss data, pros and cons of use of various classes of treatments, approaches to monitoring the disease, and changing treatment based on patient and disease characteristics.
Experts in psychiatry focus on treatment options for major depressive disorder (MDD). The discussion centers on data with newer mechanisms of action, new and emerging treatment options, and management of MDD in specific patient populations and how new treatments are aiming to fulfill unmet needs in MDD.
Advanced practice providers in dermatology discuss the treatment landscape for the management of plaque psoriasis. They review available and emerging treatment options, highlighting recent approvals and long-term safety and efficacy data.
Rheumatology specialists discuss challenges in the management of rheumatoid arthritis (RA), and how the trial-and-error approach to treatment selection and continued use of ineffective treatments impacts quality of life in RA. The panel discusses tools available to guide treatment selection and how personalization of care can improve treatment outcomes.